First Header Logo Second Header Logo

An evaluation of baricitinib as a therapeutic option for adult patients with moderate to severe atopic dermatitis.

Mendes JT, Balogh EA, Strowd LC, Feldman SR. An evaluation of baricitinib as a therapeutic option for adult patients with moderate to severe atopic dermatitis. Expert Opin Pharmacother. 2020 Jun; 21(9):1027-1033.

View in: PubMed